Carboplatin and Hepatitis c - a phase IV clinical study of FDA data

Summary:

Hepatitis c is reported as a side effect among people who take Carboplatin (carboplatin), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Vicodin, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Hepatitis c when taking Carboplatin. It is created by eHealthMe based on reports of 127,949 people who have side effects when taking Carboplatin from the FDA, and is updated regularly.

What is Carboplatin?

Carboplatin has active ingredients of carboplatin. It is often used in cancer. eHealthMe is studying from 128,210 Carboplatin users. Check the latest studies of Carboplatin.

What is Hepatitis c?

Hepatitis c is found to be associated with 787 drugs and 984 conditions by eHealthMe. Check the latest studies of Hepatitis c.

On Jul, 19, 2026

127,949 people reported to have side effects when taking Carboplatin.
Among them, 39 people (0.03%) have Hepatitis c.

Among these 39 people:

How long have people been on Carboplatin when they have Hepatitis c? *

What is the gender of people who have Hepatitis c when taking Carboplatin? *

female: 37.14 %
male: 62.86 %

What is the age of people who have Hepatitis c when taking Carboplatin? *

What are other drugs people take besides Carboplatin? *

What are other side effects people have besides Hepatitis c? *

Thrombocytopenia (decrease of platelets in blood): 12 people, 30.77%
Fatigue (feeling of tiredness): 10 people, 25.64%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 9 people, 23.08%
Pain: 9 people, 23.08%
Metastases To Liver (cancer spreads to liver): 9 people, 23.08%
Metastases To Bone (cancer spreads to bone): 8 people, 20.51%
Osteonecrosis Of Jaw (death of bone of jaw): 8 people, 20.51%
Oedema (fluid collection in tissue): 8 people, 20.51%
Decreased Interest: 8 people, 20.51%
Metastases To Lung (cancer spreads to lung): 8 people, 20.51%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 10 people, 25.64%
Resorption Bone Increased: 8 people, 20.51%
Lung Neoplasm Malignant (cancer tumour of lung): 6 people, 15.38%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 7.69%
Insomnia (sleeplessness): 1 person, 2.56%
Endometrial Cancer: 1 person, 2.56%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 2.56%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 1 person, 2.56%
Inflammatory Carcinoma Of Breast Stage Iv: 1 person, 2.56%
Stress And Anxiety: 1 person, 2.56%

* Approximation only. Some reports may have incomplete information.

Do you take Carboplatin and have Hepatitis c?

- Check whether Hepatitis c is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carboplatin:

Carboplatin (128,210 reports)

Hepatitis c treatments and more:

Hepatitis c (131,813 reports)

Browse all side effects of Carboplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis c:

Hepatitis c (787 drugs)

Browse all the conditions that are associated with Hepatitis c:

Hepatitis c (984 conditions)

Related publications that referenced our studies

Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .
Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on carboplatin (the active ingredients of Carboplatin) and Carboplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.